Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica

Veterinary Microbiology

Volumn 94, Issue 4, 2003, Pages 313-323

  Rajeev, Sreekumari ^a   Nair, Rajeev V ^b   Kania, Stephen A ^c   Bemis, David A ^c  

^a Animal Disease Diagnostic Laboratory   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Atrophic rhinitis; Bordetella bronchiseptica; Live bacterial vector; Toxins

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIAL VACCINE; EPITOPE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; ATROPHIC RHINITIS; BORDETELLA BRONCHISEPTICA; CONTROLLED STUDY; DISEASE CONTROL; DRUG SELECTIVITY; ELECTROPORATION; FEMALE; GENE CONSTRUCT; GENE CONTROL; GENE ISOLATION; HOST; INOCULATION; LETHALITY; LUNG LAVAGE; MOLECULAR CLONING; MOUSE; MULTIGENE FAMILY; NONHUMAN; PASTEURELLA MULTOCIDA; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; PROVOCATION TEST; RESPIRATORY SYSTEM; SEPARATION TECHNIQUE; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; BROAD HOST RANGE PLASMIDS; PASTEURELLA; PASTEURELLA MULTOCIDA;

EID: 0038460958     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(03)00137-8     Document Type: Article

References (30)

1. Burns E.H. Jr., Norman J.M., Hatcher M.D., Bemis D.A. Fimbriae and determination of host species specificity of Bordetella bronchiseptica. J. Clin. Microbiol. 3:1993;1838-1844.
2. Chanter N., Magyar T., Rutter J.M. Interactions between Bordetella bronchiseptica and toxigenic Pasteurella multocida in atrophic rhinitis of pigs. Res. Vet. Sci. 7:1989;48-53.
3. Daniel G.M., Freese W., Henry S., Stevermer E., Straw B., Switzer W.P. An up-to-date review of atrophic rhinitis. Vet. Med. 1:1986;5-744.
4. De Jong M.F., Akkermans J.P.W.M. Investigation into pathogenesis of atrophic rhinitis. I. Atrophic rhinitis caused by Bordetella bronchiseptica and Pasteurella multocida and the meaning of a thermolabile toxin of P. multocida. Vet. Quart. 8:1986;204-214.
5. Foged N.T. The Pasteurella multocida toxin. The characterization of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs. APMIS Suppl. 25:1992;1-56.
6. Foged N.T., Nielson J.P., Jorsal S.E. Protection of pigs against progressive atrophic rhinitis with Pasteurella multocida toxin purified by monoclonal antibodies. Vet. Rec. 125:1989;7-11.
7. Galen J.E., Levine M.M. Can a flawless live vector vaccine be engineered? Trends Microbiol. 9:2001;372-375.
8. Galen J.E., Nair J., Wang J.Y., Wasserman S.S., Tanner M.K., Sztein M.B., Levine M.M. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD908-htrA. Infect. Immun. 67:1999;6424-6433.
9. Goodnow R.A. Biology of Bordetella bronchiseptica. Microbiol. Rev. 44:1980;722-738.
10. Hamilton T.D., Roe J.M., Webster A.J.F. Synergistic role of gaseous ammonia in etiology of Pasteurella multocida-induced atrophic rhinitis in swine. J. Clin. Microbiol. 34:1996;2185-2190.
11. Kamp E.M., Kimman T.G. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacteria free crude extract and purified dermonecrotic toxin of P. multocida. Am. J. Vet. Res. 49:1988;1844-1849.
12. Kovach M.E., Elzer P.H., Hill D.S., Robertson G.T., Farris M.A., Roop R.M. II, Peterson K.M. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene. 166:1995;175-176.
13. Magyar T., Rimler R.B. Detection and enumeration of toxin producing Pasteurella multocida with a colony blot assay. J. Clin. Microbiol. 29:1991;1328-1332.
14. Mattoo S., Miller J.F., Cotter P.A. Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect. Immun. 68:2000;2024-2033.
15. McDonough P.L., Jocobson R.H., Timoney J.F., Mutalib A., Kradel D.C., Chang Y.F., Shin S.J., Lein D.H., Trock S., Wheeler K. Interpretations of antibody responses to Salmonella enterica serotype enteritidis gm flagellin in poultry flocks are enhanced by a kinetic-based enzyme linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 5:1998;550-555.
16. Mielcarek N., Cornette J., Schacht A.M., Pierce R.J.R., Locht C., Capron A., Riveau G. Intranasal priming with recombinant B. pertussis for the induction of a systemic immune response against a heterologous antigen. Infect. Immun. 65:1997;544-550.
17. Mielcarek N., Nordstorm I., Menozzi F.D., Locht C., Homgren J. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis. Infect. Immun. 68:2000;485-491.
18. Nagano H., Nakai T., Horiguchi Y., Kume K. Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin producing ability. J. Clin. Microbiol. 26:1988;19830-19837.
19. Nair, R.V., 2000. Construction of recombinant Pasteurella multocida toxin fragments and evaluation of their immunogenicity and protective efficacy in mice. Thesis. University of Tennessee.
20. Quinn, P.J., 1994. Clinical Veterinary Microbiology. Wolfe, London, pp. 280-283.
21. Rajeev, S., 2002. Bordetella bronchiseptica a candidate mucosal vaccine vector. Dissertation. University of Tennessee, Knoxville.
22. Rajeev S., Kania S.A., Nair R.V., McPherson J.T., Moore R.N., Bemis D.A. Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment. Vaccine. 19:2001;4842-4850.
23. Renauld-Mongenie G., Meilcarek N., Cornette J., Schat A.M., Capron A., Riveau G., Locht C. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Proc. Natl. Acad. Sci. 93:1996;7944-7949.
24. Rhodes M.B., New C.W.J.R., Baker P.K., Hogg A., Underdahl N.R. Bordetella bronchiseptica and toxigenic Type D Pasteurella multocida as agents of severe atrophic rhinitis of swine. Vet. Microbiol. 13:1987;179-187.
25. Roop R.M. II, Veit H.P., Sinsky R.J., Veit S.P., Hewlett E.L., Kornegay H.T. Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis in experimentally infected neonatal swine. Infect. Immun. 55:1987;217-222.
26. Rutter J.M. Atrophic rhinitis in swine. Adv. Vet. Sci. Comp. Med. 29:1985;239-279.
27. Rutter J.M., Rojas X. Atrophic rhinitis in gnotobiotic piglets: differences in the pathogenicity of Pasteurella multocida in combined infections with Bordetella bronchiseptica. Vet. Rec. 49:1982;1844-1849.
28. Snyder N.H., Banks S., Murphy B.R. Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme linked immunosorbent assay. J. Clin. Microbiol. 26:1988;2034-2040.
29. Stevenson A., Roberts M. Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens. Vaccine. 20:2002;2325-2335.
30. Victor C.W., Wilson B.C., Peralta J.M. Quantitative, single-tube kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA). Meth. Enzymol. 92:1983;391-403.